Cytometry Part A

High-dimensional cytometry technologies such as flow cytometry (FCM) and mass cytometry (CyTOF) are central to immunophenotyping in research and clinical practice. While manual gating remains the standard for cell population annotation, it is time-consuming, difficult to scale, and subject to inter-operator variability. Supervised annotation methods have emerged as a way of scaling manual annotation work, yet independent benchmarks for comparing these tools remain limited and quickly become outdated. This study presents a reproducible and extensible benchmark of supervised cytometry annotation tools implemented within the OmniBenchmark framework. Five supervised annotation methods were evaluated, spanning linear models, nearest-neighbor approaches, tree-based classifiers, mixture-rule systems, and deep learning, across eight publicly available datasets carefully selected to cover technologies, tissues, panel designs, and healthy and disease contexts. Using a sample-centric cross-validation design that reflects common reference-mapping scenarios, overall and per-population F1 scores, performance on rare populations, runtime, and robustness to reduced training set sizes was tested. Performance varied substantially across datasets and was not fully explained by dataset size or dimensionality, highlighting both operator dependence in annotation and the importance of biological context, cohort heterogeneity, and population imbalance. Less prevalent populations (<1%) remained a key challenge for most methods. Downsampling analyses showed that moderate reference sizes were often sufficient to achieve near-maximum performance. Rather than ranking methods, this benchmark provides a standardized and transparent framework for evaluating annotation tools under realistic deployment conditions. As a living resource, the OmniBenchmark implementation supports continuous integration of new datasets, tools, and metrics for both tool developers and end users annotating datasets. This enables ongoing, reproducible method comparison and informed tool selection for diverse cytometry applications.

BackgroundImaging flow cytometry (IFC) provides a high quantity of single-cell morphological data, yet the field lacks open access tools for designing interpretable, bespoke parameters. In particular, rare and atypical cell populations where well annotated data is limited, are negatively affected. ResultsWe present Flow cytometry Feature Importance (FlowFI), an open-source graphical software for bespoke image parameter design and analysis. FlowFI provides a suite of image parameter options combining data across multiple channels and markers, tailored digital noise reduction (reducing noise resulting from common flow cytometry ultra-high image acquisition modalities), and a scalable, unsupervised feature selection pipeline that allows experimentalists to refine image-derived parameters iteratively, with a novel ensemble subsampling approach that provides robust feature importance scoring. We validated FlowFI using data from a rare and heterogenous bone marrow cell type, megakaryocytes, demonstrating that the tool can successfully identify novel, discriminatory morphological features to improve the purity of selected cell populations and gating strategy. ConclusionFlowFIs core functionalities are interacted with through an intuitive user interface for researchers with options to export data directly to common image and flow cytometry software formats. With this in mind, FlowFI offers a scalable way to both feature design, and feature refinement using a range of approaches to manifold learning, augmented by a data efficient bootstrap subsampling approach for unsupervised parameter recommendations in the big data regime. The software also introduces a new feature selection measures based on common manifold learning methods in the space inspired by the Uniform Manifold Approximation and Projection (UMAP) algorithm and finds performance comparable to existing methods. FlowFI provides a versatile testing ground for future developments in broad and dynamically developing areas of research including single cell analysis, label-free sorting and intra- and inter-cellular interaction analysis, while ensuring interoperability with current research workflows. Desktop installation options as well as detailed documentation can be found at https://github.com/EarlhamInst/FlowFI

Flow cytometry is an essential tool for diagnosis of hematologic malignancies, but existing clinical workflows are highly dependent on expert manual interpretation. Existing machine learning approaches typically require extensive labeled data and are sensitive to variability in panel design, instrumentation, and laboratory workflows, limiting their generalizability. We present EventHorizon, a self-supervised foundation model for clinical flow cytometry that produces unified specimen-level representations from heterogeneous multi-panel data. EventHorizon employs a two-stage hierarchical transformer architecture with marker-aware tokenization, enabling seamless integration of cells measured across different antibody panels into a single shared latent space. We pre-train the model using a DINO-inspired self-distillation strategy with a variety of flow cytometry-specific augmentations on a dataset of more than 100,000 clinical specimens across 17 distinct panels. We evaluate the resulting embeddings on three clinically relevant classification tasks spanning common and rare panels, demonstrating that simple k-nearest neighbor probing of frozen EventHorizon embeddings achieves performance comparable to a fully supervised baseline model and a prior panel-specific self-supervised model. To ensure EventHorizon is not simply shortcut learning on features such as the markers/panels run for a given specimen, we perform a graph-theoretic analysis of EventHorizons latent space which argues that specimen embeddings are organized primarily by biological diagnosis. Taken together, these results demonstrate that EventHorizon produces biologically meaningful, panel-agnostic specimen representations from clinical flow cytometry data which, with further development and validation, could provide a potential basis for scalable, reproducible diagnostic support across diverse clinical laboratory settings.

High parameter cytometry is essential for clinical diagnostics through precise immune cell profiling, improved patient stratification, and monitoring, while also enhancing the understanding of cellular responses in disease and therapeutic contexts. The amount of cytometry data is growing fast, and with that, the need to merge different datasets for unified analysis. Here, we present CyStainer, a transformer-based variational autoencoder that demonstrates competitive or superior performance to existing methods on several key tasks related to marker prediction. As a key novelty, we demonstrate that CyStainer can impute markers without having a set of shared backbone markers. We performed several benchmarks using real-world FACS, CyTOF, InfinityFlow and CITE-seq datasets to show that CyStainer is a robust and flexible tool for panel merging, marker imputation, dataset integration and virtual staining of unseen samples.

Abstract/SummaryWe present a streamlined protocol that enables the characterization of the metabolic state of immune cell populations through their distinct NADH/FAD autofluorescence fingerprints using a FACSymphony A5 spectral cytometer. We demonstrate the utility of this approach by profiling the metabolic status of diverse splenic B-cell subsets and assessing metabolic changes associated with their activation state.

High-dimensional single-cell technologies, such as flow cytometry and CITE-Seq, typically rely on established lineage markers to define cell identities. Additional markers are commonly analyzed within the context of these predefined cell types. Nonlinear projection methods such as t-SNE and UMAP provide a visual framework for this analysis by enabling the overlay of cell types and marker expression. However, these methods frequently produce projections where distinct cell types substantially overlap, hindering interpretation of marker expression patterns relative to known cell types. In this study, we investigate the underlying causes of this phenomenon and demonstrate that such overlaps often stem from the inherent high-dimensional structure of the data rather than limitations in the dimensionality reduction algorithms themselves. To address this, we introduce Cell Type Weighted Dimensionality Reduction (CWDR), a novel approach that incorporates lineage-based information through a supervised weighting mechanism. By integrating both cell identity and marker expression, CWDR preserves the visual separation between predefined cell types while maintaining the local variance necessary for downstream analysis. We validate our method across multiple high-dimensional flow cytometry and proteogenomic datasets. Our results show that CWDR significantly reduces inter-cluster overlap compared to traditional methods, providing a clearer framework for visualizing marker expression within the context of specific cell lineages.

Automated analysis of murine bronchoalveolar lavage fluid (BALF) cytology is important for preclinical respiratory research, yet progress has been limited by the lack of publicly available, well-annotated mouse BALF image datasets. We present MurineCyto-Det, a high-resolution murine BALF cytology dataset comprising 333 image tiles of size 1024x1024 pixels, annotated across five cytological categories with both pixel-level segmentation masks and one-to-one matched bounding boxes. The dataset contains 14,551 annotated cell instances and supports two complementary analysis tasks: morphology-oriented cell segmentation and object-level cell detection. To establish reproducible benchmark baselines, we evaluated representative segmentation and detection models. The results demonstrate the practical utility of MurineCyto-Det while highlighting realistic challenges arising from class imbalance, small object size, irregular cell morphology, and ambiguous debris-like structures. MurineCyto-Det provides a standardized resource for developing, evaluating, and comparing automated methods for murine BALF cytology analysis. The dataset is publicly available at https://doi.org/10.5281/zenodo.17608677.

Accurate identification and quantification of eosinophils is critical for the diagnosis and monitoring of eosinophil-associated disorders. While flow cytometry remains a powerful tool for leukocyte characterization, conventional instruments equipped with 405 nm or 488 nm side scatter (SSC) detectors offer limited resolution for eosinophil discrimination overlap in scatter with neutrophils. Using a spectral flow cytometer equipped with six distinct SSC detectors, we report a novel, label-free approach for eosinophil detection leveraging high 808 nm near-infrared SSC (IRSSC) uniquely observed in human eosinophils. This optical signature is independent of antibody labeling, activation fixation, or permeabilization, and shows strong concordance with conventional CD66b/CD16 gating strategies (R = 0.997). Notably, the high 808 nm SSC is absent in murine eosinophils, suggesting a species-specific structural feature such as in human eosinophils. These findings establish IRSSC as a robust, reagent-free biomarker for eosinophil detection, with broad implications for both clinical diagnostics and translational immunology.

BackgroundPeripheral blood smears (PBS) review is labor-intensive, subjective, and challenging for rare or morphologically heterogeneous cell types in hematologic malignancies. Artificial intelligence (AI) offers a scalable alternative, but broader clinical translation is constrained by annotation burden and limited interpretability. MethodsWe developed an interpretable, annotation-efficient AI framework that learns leukocyte morphology through a two-stage process: label-free representation learning to construct a morphological embedding space, followed by supervised fine-tuning for cell type and morphological attribute classification. The model was trained and evaluated on 5,952 PBS images from cancer patients at MD Anderson Cancer Center, including blast cells, and 17,092 images from public sources. Active learning strategies were assessed to improve label efficiency, and interpretability was examined using saliency and embedding visualization. An interactive web application, HemoSight, was developed to support clinical review. FindingsThe framework achieved a macro-F1 score of 0{middle dot}96 for 9-way leukocyte classification on the internal test split and 0{middle dot}83 on the held-out patient cohort. Active learning substantially reduced annotation requirements, reaching peak performance with only 13{middle dot}3% of available labels and significantly improving learning efficiency across 8 of 9 cell types. The model generalized to classifying 11 leukocyte morphological attributes with a mean F1 score of 85{middle dot}8% and revealed structured morphological landscapes. Saliency maps, embedding visualizations, and the HemoSight application enabled transparent morphological inspection of model predictions, supporting confidence in model behavior and feasibility for clinical integration. InterpretationOur framework enables scalable, annotation-efficient, and interpretable modeling of leukocyte morphology, supporting the integration of AI-assisted PBS review for hematopathology workflows. FundingSeed funding from The University of Texas MD Anderson Cancer Center. Research in ContextO_ST_ABSEvidence before this studyC_ST_ABSPeripheral blood smear review is essential for diagnosing and monitoring hematologic malignancies, but manual case review is time-consuming and variable, particularly for rare or abnormal leukocyte types. Automated hematology analyzers are widely used to flag abnormal cells; however, they provide limited morphological insight and often require frequent manual correction, especially in cancer settings where disease and treatment alter cell appearance. Previous artificial intelligence approaches for leukocyte classification have shown promise, but most rely on fully supervised learning, require extensive expert annotation, focus on a limited set of cell types, and frequently exclude diagnostically important rare cells such as blasts. Interpretability is inconsistently addressed, and few studies provide tools that allow clinicians to inspect and interpret model outputs within routine workflows. Added value of this studyThis study introduces an annotation-efficient framework trained on a large collection of peripheral blood smear images, including cancer patient samples with hematopathologist-verified rare cell types such as blasts. The framework learns leukocyte morphology from unlabeled images and adapts to multiple classification tasks with minimal expert labeling. Performance is evaluated on both internal test splits and a held-out patient cohort to provide a realistic estimate of generalization. Iterative, uncertainty-guided annotation substantially reduces labeling requirements while improving learning efficiency across most leukocyte classes. Beyond cell-type classification, the framework is extended to 11 clinically relevant morphological attributes and reveals a structured morphological landscape. These capabilities are integrated into a web application, HemoSight, enabling real-time inference and transparent morphological inspection of predictions within hematopathology workflows. Implications of all the available evidenceAdvancing artificial intelligence for hematology requires methods that reduce expert labeling demands, provide interpretable outputs, and perform reliably across clinically diverse patient samples. This study shows that learning from largely unlabeled data combined with iterative expert annotation can support scalable and flexible modeling of leukocyte morphology for classification tasks. Integrating quantitative predictions and interactive visualization supports the use of artificial intelligence as an assistive tool for diagnostic peripheral blood smear review, with potential to improve efficiency, consistency, and reviewer confidence.

Multiplexed imaging technologies enable the simultaneous measurement of dozens of protein markers while preserving context, providing a high-resolution view of tissue organization schemes. However, extracting meaningful insights from these high-dimensional datasets--particularly in hyperplex settings (>20 markers)--remains a major computational challenge, especially in the absence of annotated data. Here, we present UMITIC (Unsupervised Analysis of Multiplex Images via TIssue Characterization), a modular and unsupervised computational framework for the joint characterization of cell phenotypes and tissue neighborhoods from multiplex imaging data. UMITIC integrates three components: (i) CellCut, a strategy that combines nuclear and cytoplasmic predictions to improve the delineation capabilities of the framework; (ii) CellMap, a contrastive learning approach that generates low-dimensional representations of single-cell image crops that are enriched with morphological features; and (iii) TissueNet, a graph neural network that models spatial cell-cell interactions to identify tissue neighborhoods. We evaluated UMITIC across four datasets of increasing complexity to assess its robustness, scalability and biological relevance. With respect to a 7-plex human tonsil dataset, the framework identified canonical immune cell populations and reconstructed well-established anatomical regions. When applied to a 43-plex tonsil image, UMITIC preserved these tissue-level structures while enabling a finer cell subtype stratification process driven by increased marker dimensionality. We further validated our method on a 58-plex colorectal cancer cohort, where UMITIC was able to recover previously reported immune composition differences and spatial organization variations between patient groups with different prognoses. Finally, when an expert-annotated mass cytometry imaging dataset concerning human lung tissue was used, UMITIC achieved higher agreement with the reference tissue annotations than the existing approaches did, demonstrating improved lung microanatomy reconstruction accuracy. Together, these results show that UMITIC enables consistent and interpretable analyses of both cellular phenotypes and tissue architectures across diverse multiplex and hyperplex imaging datasets without the need for manual annotations. Author summaryUnderstanding how cells are organized within tissues is fundamental to deciphering diseases, yet analyzing tissue imaging data remains a major challenge. The recently developed imaging technologies enable the visualization of dozens of proteins in a single tissue section, revealing unprecedented cell identity and spatial organization details. However, extracting meaningful biological insights requires extensive manual annotation work performed by expert pathologists, limiting the scalability. Here, we present a fully automated computational framework that characterizes tissue architectures in an unsupervised manner at two complementary levels: it identifies cell types based on their protein expressions and morphologies and maps how those cells are organized into spatially coherent tissue structures, and it does so without requiring any manual annotations. Our approach is modular and interpretable at the cell level. We validated our framework across four independent datasets with panels consisting of 7 to 58 simultaneous protein markers, including healthy human tissue and a colorectal cancer cohort in which patients with distinct immune profiles were analyzed. Remarkably, UMITIC improved upon the performance of existing methods across both qualitative and quantitative assessments. These results suggest that our framework provides objective, interpretable and reproducible image processing tools for conducting tissue analyses in both research and clinical settings.

Global mRNA translation is a defining functional property of hematopoietic stem cells (HSCs) and is increasingly recognized as a critical axis of dysregulation in myelodysplastic syndromes (MDS) and other clonal hematopoietic disorders. Yet the quantitative measurement of protein synthesis at single-cell resolution across phenotypically defined HSPC subpopulations, in parallel with apoptotic state, is technically challenging. Here we describe and validate a single-tube flow cytometry protocol that simultaneously quantifies global protein synthesis by O-propargyl-puromycin (OP-Puro) incorporation and intracellular cleaved Caspase-3 with cell immunophenotyping across the canonical CD34+ HSPC hierarchy in cryopreserved human cord blood (CB) CD34+ cells. The protocol enables quantitative assessment of key dynamic cell processes in defined subsets of primary hematopoietic cells on a standard flow cytometer. We apply this assay to a four-condition factor-omission analysis of the canonical SR1 + UM729 + dmPGE2 ex vivo expansion cocktail across three independent CB donors. The analysis assigns each compound a distinct functional profile: UM729 constrains protein synthesis and supports apoptotic priming across the hierarchy; SR1 maintains a pro-survival state without modulating translation; and dmPGE2 promotes HSC cycling and progressive exit from the primitive state, with minimal direct effect on the translation or apoptotic axes measured here. This analysis resolves three mechanistically distinct small-molecule signatures using a protocol directly transferable to clinical biobank specimens. We propose it as a functional-state analytic platform that may be useful for patient-derived CD34+ cells from MDS and other myeloid neoplasms in which translational dysregulation is a recognized pathological feature.

BackgroundSingle-cell multi-omics profiling of hematopoietic malignancies frequently involves pooling of patient samples before library preparation to reduce costs. Demultiplexing and quality control of the resulting sequencing data depend on experimental design, sequencing depth, and computational methods. Existing approaches benchmark individual tools, auto-select a single best method, or apply majority voting. However, none systematically exploit disagreement patterns among orthogonal strategies as a diagnostic signal for cell quality. ResultsWe introduce Split-flow, a modular Nextflow pipeline that runs hashing-based and SNP-based demultiplexing, and transcriptome-based doublet detection in parallel. It classifies cells into quality strata through a concordance-based decision framework. Validation on multiplexed CITE-seq data from 14 multiple myeloma patients across eight Chromium channels demonstrates high reproducibility and shows that discordant cells cluster within specific cell types and quality strata. TCR clonotype cross-referencing against VDJdb confirms that concordance-based classification enriches for biologically genuine immune receptor sequences, with a 5.3-fold enrichment of confirmed public TCR sequences in the high-confidence stratum. Downsampling analysis reveals that SNP-based methods are more depth-sensitive than hash-based approaches, supporting the recommendation to combine both strategies. The framework transfers to AML samples across three assay types (snMultiome-seq, scRNA-seq, scATAC-seq), where ATAC-based demultiplexing resolves donor assignment discordance under low hashing efficiency. ConclusionsSplit-flow demonstrates that combining of orthogonal preprocessing methods yields structured information about cell quality and offers a concordance-based framework that transforms this disagreement into a diagnostic signal. It introduces a preprocessing approach that can be exploited beyond hematopoietic malignancies in multiplexed single-cell applications. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=114 SRC="FIGDIR/small/724135v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@1f36dbcorg.highwire.dtl.DTLVardef@a9799forg.highwire.dtl.DTLVardef@6fca94org.highwire.dtl.DTLVardef@15cc1f3_HPS_FORMAT_FIGEXP M_FIG C_FIG Highlights and main findingsO_LIIntroduces Split-flow, a modular Nextflow DSL2 pipeline for preprocessing of multiplexed single-cell multi-omics sequencing data from hematopoietic malignancy samples via a post hoc concordance-based decision framework. C_LIO_LIProvides practical guidance for the experimental design of multiplexed single-cell multi-omics experiments, including the recommendation to combine antibody-based hashing with a SNP genotype reference for orthogonal demultiplexing. C_LIO_LIReveals that SNP-based demultiplexing is more sensitive to sequencing depth than hash-based approaches, and that the combined strategy mitigates depth-dependent biases in cell-type recovery. C_LIO_LIDemonstrates that disagreement between demultiplexing methods contains structured diagnostic information about cell quality, with concordance categories reflecting genuine quality gradients in multiple myeloma CITE-seq samples. C_LIO_LIValidates the concordance framework using T cell receptor sequences as an orthogonal biological readout, with a 5.3-fold enrichment of confirmed public TCR sequences in the high-confidence stratum. C_LIO_LIApplies the preprocessing framework to AML patient samples across three assay types (snMultiome-seq, scRNA-seq, and scATAC-seq) and demonstrates that ATAC-based demultiplexing can resolve donor-assignment discordance. C_LI

Rapidly detecting infectious diseases such as Covid-19 is essential to control outbreaks and treat patients early. However, no available screening method combines low cost, portability, speed (<20 min, ideally <5 min), and ultrasensitivity (e.g., <1 virus/L): lateral flow assays are fast, portable, and inexpensive but insensitive, whereas ultrasensitive assays require centralized labs with long turnaround times. We recently developed an ultrasensitive immunoassay that captures, separates, and counts saliva biomarker molecules using buoyant microbubbles and magnetic microspheres, but the original assay took 55 minutes and was not readily deployable. Here, we redesigned the assay protocol and reader for emergency medicine and mobile care by streamlining the workflow, collecting saliva with larger swabs, filtering it through a 10 m cap, and using larger microbubbles to accelerate flotation. A paramedic successfully ran the assay on the back of a parked medical van in 3.5 minutes (spit-to-results) while achieving a 1.3 fg/mL analytical detection limit for SARS-CoV-2 nucleocapsid protein (~0.04 virus1/L). The assay remained positive across 9 orders of magnitude. We describe the challenges and opportunities ahead for point-of-care deployment.

With the introduction of dedicated nanoscale flow cytometers, the need for suitable compensation beads has emerged. Here, we present a rapid and cost-effective method to generate [~]100 nm antibody-binding compensation beads compatible with a wide range of antibody species for use in nanoscale flow cytometry. This approach may provide a practical interim solution until commercial alternatives become available.

Flow cytometry produces high-dimensional single-cell protein measurements central to immunophenotyping and clinical monitoring. Yet analysis still relies largely on manual gating, which is labour-intensive, poorly reproducible, and ill-suited to large marker panels. Existing computational approaches address classification or discovery in isolation, treating cell-type identity as a post-hoc annotation rather than as part of the generative model itself. We present MARVIN, a semi-supervised variational autoencoder that encodes the assumption that cells organise into discrete populations with continuous intra-population variability through a Gaussian mixture prior in the latent space. Because each component represents a distinct cell population, classification, discovery, and density estimation emerge as complementary views of the same representation. On public benchmarks, MARVIN matches or exceeds existing methods using as few as 10% labelled cells. Trained exclusively on healthy samples, it identifies leukaemic cells through elevated reconstruction error, providing an unsupervised anomaly detection signal. On paired stimulation data, it maintains stable population assignments while capturing condition-specific shifts in abundance and marker expression at patient-level resolution. MARVIN is open-source and designed for local deployment, adapting to institution-specific panels and instruments

Nephrons are the functional units of the kidney; within each nephron, the glomerulus is the initial site of selective filtration that allows removal of waste products while preserving proteins in the bloodstream. Each glomerulus consists of a network of capillaries surrounded by specialized epithelial cells, podocytes, which mediate selective filtration. Abnormalities in glomerular structure impair renal function, resulting in proteinuria and kidney disease. Although several microscopy-based approaches exist to characterize glomerular architecture and structural abnormalities, quantitative analysis is often limited by labor-intensive image segmentation. In this study we present a semi-automated approach for segmentation and analysis of glomerular architecture from three-dimensional confocal microscopy data. Using mTmG transgenic mice that express membrane-associated EGFP in podocytes and membrane-associated tdTomato across all other cell types, we reconstruct podocyte processes and glomerular capillaries from volumetric renal images. This semi-automated approach reduces manual segmentation effort and supports more efficient, standardized analysis of glomerular architecture in three-dimensional confocal microscopy datasets.

Microscopic images of cells and tissues are central to disease diagnosis. In computational pathology, multiple instance learning (MIL) has emerged as a key paradigm for analyzing numerous images within a single patient sample. While the representative distribution of cells in a sample is important for diagnosis, existing MIL frameworks largely overlook it. We introduce TopoMIL, a framework that extracts the representative topological structure of the sample and integrates it into the MIL classifier. Three topological representations are assessed, each with distinct advantages and computational costs. We evaluate TopoMIL on four histopathology and cytomorphology datasets, each presenting unique challenges. Integrating the samples topological information into MIL enhances classification across average, max, attention-based, and transformer pooling, yielding AUCROC gains of 3.3%, 4.2%, 5.9%, and 0.5%, respectively, with moderate computational cost. Our work underscores the potential of TopoMIL as a scalable extension to existing morphology-based models in computational pathology.

Understanding the behavior of - and {beta}-cells within intact human islets is essential for elucidating mechanisms of metabolic control in diabetes. Current cell-type identification strategies rely on destructive labeling or on advanced imaging modalities such as Fluorescence Lifetime Imaging Microscopy (FLIM), which provide rich metabolic information but require specialized instrumentation and acquisition protocols. Here we show that structured intracellular intensity patterns derived from endogenous autofluorescence are sufficient to discriminate and {beta} cells in living human islets. Using rotation-invariant Local Ternary Pattern (LTP) descriptors combined with morphological features, we achieve highly accurate classification (AUC = 0.92), improving upon previously reported benchmarks. The resulting framework is lightweight, interpretable, and compatible with standard imaging configurations, enabling accessible and scalable analysis of label-free microscopy data. Interpretability analyses demonstrate that discrimination is driven predominantly by fine-scale intracellular intensity organization rather than global morphology. In the spectral window employed, cytoplasmic autofluorescence is prominently shaped by lipofuscin-rich granules. Consistent with prior reports of higher lipofuscin accumulation in {beta}-cells, the dominant features identified here likely reflect differences in granule abundance and spatial organization between endocrine cell types. These findings indicate that endogenous intensity patterns encode sufficient structural information for reliable /{beta} discrimination, providing a biologically grounded and fully non-destructive framework for the identification of pancreatic islet cell types.

Metastasis remains the major cause of cancer-related mortality, and circulating tumor cells (CTCs) are both candidate liquid-biopsy biomarkers and plausible intermediates of metastatic dissemination. Because CTCs are extremely rare in peripheral blood, platform comparisons have often focused solely on recovery. That focus is insufficient for applications that depend on the quality of the recovered material, including single-cell profiling, short-term culture, and functional testing. Here, we compared four CTC isolation approaches: TellDx CTC System, Genesis System, RosetteSep, and flow cytometry, using spike-in experiments in human blood. Capture efficiency was evaluated across all four platforms; purity was assessed for TellDx, Genesis, and RosetteSep; and post-isolation GFP signal persistence in culture was assessed for TellDx and Genesis as an exploratory proxy for short-term post-isolation preservation. Under the conditions tested, TellDx showed the highest recovery (88.1% {+/-} 3.7%), followed by Genesis (40.6% {+/-} 12.1%), RosetteSep (36.5% {+/-} 9.0%), and flow cytometry (7.6% {+/-} 4.5%). TellDx also showed the highest purity score (3.76), whereas Genesis (2.25) and RosetteSep (2.09) did not differ substantially. In the short-term culture assay, TellDx-derived samples retained a higher normalized GFP signal than Genesis-derived samples at 48 h and 72 h. To synthesize these readouts, we propose the Recovery Performance Index (RPI), a composite score integrating recovery, purity, and post-isolation signal persistence. Within this experimental framework, TellDx achieved the highest RPI. These data support two conclusions. First, platform benchmarking for CTC workflows benefits from multidimensional evaluation rather than recovery alone. Second, under this spike-in model and within the specific workflows used here, TellDx performed best among the platforms tested. The principal contribution of this study is therefore the establishment of a practical benchmarking framework that can be expanded in future work using clinical samples, multiple CTC phenotypes, and orthogonal viability assays.

Multiplex staining is a technique that allows the identification of cell types within a single tissue section by simultaneously detecting multiple molecular markers. Generally, multiplex staining is performed using several combinations of probes, including specific antibodies, nucleic acid probes, and lectins. Here, a novel multiplex staining strategy that relies exclusively on lectin probes that target glycans is presented. Glycans have a vast variety of structural forms that vary depending on cell type-specific modifications. Furthermore, an enormous number of glycan-binding molecules, collectively known as lectins, exist in the biological world. Each lectin displays specificity for a particular glycan motif while maintaining broad affinity. Although lectin-based cell staining has been used in various applications, the partial and limited specificity of lectins has hindered the use of glycan-targeted multiplex staining with lectins. In addition, lectin probes have largely been avoided for cell-type identification because of the absence of strict cell-type-specific glycans. Here, a novel staining method, Glycan Painting, is introduced. Rather than viewing the partial specificity of lectins and the broad, non-cell-type-specific distribution of glycans as drawbacks, this approach turns these features into advantages by generating distinct color patterns that comprehensively visualize cell-type-specific glycan combinations and enable full-color imaging of tissues.